TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 1 | 4 | 17 | 39 | 0 | 0 | 15 |
| P | %wins | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/13/22 16:27 | 7/19/22 | TALS | Talaris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nader Francois | MA | D | P.am | 500 | 3.61 | 0 | 139 | 35 | 534 | M | |||||||||||||||
7/25/22 19:35 | 7/19/22 | TALS | Talaris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nader Francois | MA | D | P.m | 500 | 3.61 | 0 | 139 | 41 | 475 | M | |||||||||||||||
11/10/11 12:03 | 11/9/11 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Nader Francois | NJ | DO | P,CEO,Di | P | 161 | 5.36 | 13 | 30 | 29 | 133 | D | 76 | -17 | -48 | -25 | -19 | -21 | 3 | -5 | 1 | 4 | 17 | 39 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |